Q1 FY27 · Ended Jun 30, 2026 · View SEC filing
Profit grew more than twice as fast as sales
Overheads rose slower than revenue, so each added dollar of sales carried far more profit than the average dollar.
For investorsWhat the margin gain depends on from here
For foundersHow a one-time machine sale becomes years of revenue
Yearly revenue kept rising while capital spending stood still, so far more of the cash from operations is left over.
Service now edges out products, but it is labor-heavy, and this quarter its costs grew faster than its revenue.
A sterilizer or endoscope reprocessor tends to commit a department to Steris consumables and service for the life of the machine.
Unlock the financial breakdown, competitive insights, historical trends and founder playbook, plus research across the company library.
Free CXProWealth membership required
Business Lens describes Steris from its own filings with the SEC. It is not a view on its shares, a target, or advice to buy, sell or hold anything; figures are as filed and may be restated by the company later. The filing is linked above.
